Safety of vaccines in pregnancy: from systematic exclusion to a causality assessment framework
Maternal immunisation is one of the most powerful preventive public health strategies. However, maternal vaccine uptake in Europe has fallen, with significant differences between countries.1–3 These differences reflect heterogeneous national recommendations and delivery strategies for maternal vaccination across Europe.
Authors
- Paul Trafford Heath (ORCID: https://orcid.org/0000-0002-7540-7433)
- Flor M. Muñoz (ORCID: https://orcid.org/0000-0002-0457-7689)
- Asma A. Khalil (ORCID: https://orcid.org/0000-0003-2802-7670)
- Abi Merriel (ORCID: https://orcid.org/0000-0003-0352-2106)
- Eileen Deuster (ORCID: https://orcid.org/0009-0004-2283-9082)
- ATHINA A. SAMARA (ORCID: https://orcid.org/0000-0001-6931-1972)
- David M. Lissauer (ORCID: https://orcid.org/0000-0002-7878-2327)
- Kirsty LeDoare
Institutions
- Goethe University Frankfurt (DE)
- St George's Hospital (GB)
- Karolinska University Hospital (SE)
- University of Liverpool (GB)
- St George's, University of London (GB)
- Baylor College of Medicine (US)
- University of Oslo (NO)
- Karolinska Institutet (SE)
- Liverpool Women's Hospital (GB)
- University Hospital Frankfurt (DE)
- Liverpool Womens NHS Foundation Trust (GB)
- NIHR Research Delivery Network (GB)
- NIHR Applied Research Collaboration North West Coast (GB)
- City St George's, University of London (GB)
Publication Details
- Journal
- The Lancet Regional Health - Europe
- Published
- 2026-10-27
- DOI
- https://doi.org/10.1016/j.lanepe.2026.101900
- Primary Topic
- Pharmacovigilance and Adverse Drug Reactions
- Type
- article
- Field-Weighted Citation Impact
- 0.00